Kaplan-Meier plots illustrating the comparison of the AMLSG 16-10 study (16-10, red) to historical controls (historical, blue). Analyses included younger (A) and older (B) patients, as well as a sensitivity analysis with censoring of alloHCT in CR1 in younger (C) and older (D) patients.